|
|
|
|
|
CUSIP No. 001282 20 1
|
|
13D/A
|
|
Page 2 of 8
|
|
|
|
|
|
|
|
1
|
|
Name of Reporting Persons.
Robert W. Decherd
|
2
|
|
Check the Appropriate Box if a
Member of a Group (See Instructions)
(a)
¨
(b)
¨
|
3
|
|
SEC Use Only
|
4
|
|
Source of Funds (See
Instructions)
PF (1)
|
5
|
|
Check if Disclosure of Legal
Proceedings is Required Pursuant to Items 2(d) or 2(e)
¨
|
6
|
|
Citizenship or Place of
Organization
United States
|
NUMBER OF SHARES
BENEFICIALLY OWNED
BY EACH REPORTING
PERSON WITH
|
|
7
|
|
Sole Voting Power
1,588,489(2)(3)
|
|
8
|
|
Shared Voting Power
4,631(2)(4)
|
|
9
|
|
Sole Dispositive Power
1,588,489(2)(3)
|
|
10
|
|
Shared Dispositive Power
4,631(2)(4)
|
11
|
|
Aggregate Amount Beneficially
Owned by Each Reporting Person
1,593,120(2)(3)
|
12
|
|
Check if the Aggregate Amount in
Row (11) Excludes Certain Shares (See Instructions)
x
|
13
|
|
Percent of Class Represented by
Amount in Row (11)
62.6%
|
14
|
|
Type of Reporting Person (See
Instructions)
IN
|
|
|
|
|
|
CUSIP No. 001282 20 1
|
|
13D/A
|
|
Page 3 of 8
|
(1) See Item 3.
(2) Series B Common Stock is convertible at any time on a share-for-share basis into Series A Common Stock.
(3) Includes 133,864 Series B shares subject to presently exercisable options or options exercisable within 60 days of the date of this Amendment No. 5 to Schedule 13D. Such number does not include
240 Series B shares owned by Mr. Decherds wife, as to all of which shares Mr. Decherd disclaims beneficial ownership.
(4)
These shares of Series B Common Stock are held by Mr. Decherd in joint tenancy with his wife.
|
|
|
|
|
CUSIP No. 001282 20 1
|
|
13D/A
|
|
Page 4 of 8
|
Item 1. Security and Issuer
Item 2. Identity and Background
Item 3. Source and Amount of Funds or Other
Consideration
Item 4. Purpose of Transaction
Item 5. Interest in Securities of the Issuer
Item 6. Contracts, Arrangements,
Understandings or Relationships with Respect to the Issuer
Item 7. Material to be Filed as Exhibits
SIGNATURE
|
|
|
|
|
CUSIP No. 001282 20 1
|
|
13D/A
|
|
Page 5 of 8
|
This Amendment No. 5 to Schedule 13D is filed to report the following changes to the information
previously disclosed in Amendment No. 4 to Schedule 13D filed February 10, 2012.
Item 1. Security and Issuer.
No material change.
Item 2. Identity and Background.
No material change.
Item 3. Source and Amount of Funds or Other Consideration.
The Reporting Persons deemed disposition reflected in this Amendment No. 5 to Schedule 13D results from the expiration on December 6, 2012, of employee stock options to acquire a
total of 40,000 shares of the Issuers Series B Common Stock. No funds were expended in connection with the foregoing deemed disposition.
Item 4. Purpose of Transaction.
The Reporting Person intends to
review his investment in the Issuer on a continuing basis and may, at any time, consistent with the Reporting Persons obligations under the federal securities laws, determine to increase or decrease his ownership of shares of the Issuers
Series A and B Common Stock through purchases or sales in the open market or in privately-negotiated transactions. The Reporting Persons review of his investment in the Issuer will depend on various factors, including the Issuers
business prospects, other developments concerning the Issuer, general economic conditions, financial and stock market conditions, the Reporting Persons personal financial situation, need for, and availability of capital, and any other facts
and circumstances which may become known to the Reporting Person regarding his investment in the Issuer. At the time of filing this Amendment No. 5 to Schedule 13D, the Reporting Person has no plans to purchase additional shares of common stock
in the open market in the immediate future. However, the Reporting Person may engage in privately-negotiated transactions in the future, may from time-to-time acquire additional shares of common stock under various benefit and compensation
arrangements of the Issuer, and reserves his right to reevaluate his investment in the Issuer and to purchase additional shares in the open market or otherwise.
|
|
|
|
|
CUSIP No. 001282 20 1
|
|
13D/A
|
|
Page 6 of 8
|
Except as may occur in the ordinary course of business of the Issuer, the Reporting Person has no present
plans or proposals that relate to or would result in (i) an extraordinary corporate transaction, such as a merger, reorganization, or liquidation, involving the Issuer or any of its subsidiaries, (ii) a sale or transfer of a material
amount of assets of the Issuer or any of its subsidiaries, (iii) any change in the board of directors or executive management of the Issuer or any of its subsidiaries, (iv) any material change in the present capitalization or dividend
policy of the Issuer, (v) any other material change in the Issuers business or corporate structure, (vi) changes in the Issuers Certificate of Incorporation or bylaws or other actions that may impede the acquisition of control
of the Issuer by any person, (vii) a series of securities of the Issuer being delisted from a national securities exchange or no longer being quoted in an inter-dealer quotation system of a registered national securities association,
(viii) a series of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, or (ix) any action similar to any of those described above.
However, the Reporting Person, in his capacity as Chairman of the Board, President and Chief Executive Officer may, from time to time, become aware of, initiate, and/or be involved in discussions that relate to the transactions described in this
Item 4 and thus retains his right to modify his plans with respect to the transactions described in this Item 4 to acquire or dispose of securities of the Issuer and to formulate plans and proposals that could result in the occurrence of
any such events, subject to applicable laws and regulations.
Item 5. Interest in Securities of the Issuer.
(a) As of the date of filing of this Amendment No. 5 to Schedule 13D, the Reporting Person beneficially owns 1,593,120 shares of the
Issuers Series B Common Stock, representing approximately 62.6% of the 2,411,556 shares of the Issuers Series B Common Stock treated as being outstanding as of October 25, 2012. Such number of shares includes 4,631 Series B shares
owned by the Reporting Person and his wife, as to which the Reporting Person shares voting and dispositive power, and 133,864 Series B shares subject to presently exercisable options or options exercisable within 60 days of the date of the filing of
this Amendment No. 5 to Schedule 13D. Such number does not include 240 Series B shares held by the Reporting Persons wife, as to all of which shares the Reporting Person disclaims beneficial ownership.
(b) As of the date of filing of this Amendment No. 5 to Schedule 13D, the Reporting Person has sole voting power and sole
dispositive power over 1,588,489 shares of the Issuers Series B Common Stock, which represents approximately 62.4% of the shares of the Issuers Series B Common Stock treated as being outstanding as of October 25, 2012. As of the
date of filing of this Amendment No. 5 to Schedule 13D, the Reporting Person has shared voting power and shared dispositive power over 4,631 shares of the Issuers Series B Common Stock, which represents approximately 0.2% of the shares of
the Series B Common Stock of the Issuer treated as being outstanding as of October 25, 2012.
(c) Except as disclosed in
Item 3, the Reporting Person has not effected any transaction involving the acquisition or exchange of shares of the Series B Common Stock of the Issuer during the past 60 days.
(d) Not applicable.
(e) Not applicable.
|
|
|
|
|
CUSIP No. 001282 20 1
|
|
13D/A
|
|
Page 7 of 8
|
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
No material change.
Item 7. Material to be Filed as Exhibits.
No material change.
|
|
|
|
|
CUSIP No. 001282 20 1
|
|
13D/A
|
|
Page 8 of 8
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
Dated: February 12, 2013
|
|
|
|
/s/ Robert W.
Decherd
|
|
|
|
|
Robert W. Decherd
|